D. Carvallo

625 total citations
11 papers, 535 citations indexed

About

D. Carvallo is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, D. Carvallo has authored 11 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in D. Carvallo's work include Biochemical and Structural Characterization (3 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). D. Carvallo is often cited by papers focused on Biochemical and Structural Characterization (3 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). D. Carvallo collaborates with scholars based in France, United States and Switzerland. D. Carvallo's co-authors include Michael Courtney, Moníque Capron, Jean‐Marc Balloul, P. Sondermeyer, Jean‐Marie Grzych, Raymond J. Pierce, Dominique Dreyer, Carolyn Roitsch, A Capron and Jean‐Pierre Lecocq and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

D. Carvallo

11 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Carvallo France 9 250 176 91 81 73 11 535
Peter W. Bergum United States 16 219 0.9× 170 1.0× 426 4.7× 76 0.9× 57 0.8× 20 913
Martine Damonneville France 11 179 0.7× 175 1.0× 32 0.4× 34 0.4× 85 1.2× 22 474
Gavin Nicoll United Kingdom 9 572 2.3× 133 0.8× 16 0.2× 24 0.3× 44 0.6× 10 950
Carolann McGuire United Kingdom 12 251 1.0× 37 0.2× 227 2.5× 20 0.2× 35 0.5× 17 659
Tamar Grossman Israel 11 227 0.9× 89 0.5× 47 0.5× 16 0.2× 127 1.7× 22 475
Graeme Woodrow Australia 12 267 1.1× 29 0.2× 113 1.2× 88 1.1× 182 2.5× 19 625
Christopher A. Seid United States 17 355 1.4× 81 0.5× 9 0.1× 32 0.4× 158 2.2× 31 794
John Swindle United States 17 438 1.8× 51 0.3× 14 0.2× 99 1.2× 180 2.5× 34 772
Jennifer Sexton United States 12 180 0.7× 100 0.6× 14 0.2× 102 1.3× 8 0.1× 18 567
Verena Karsten United States 10 157 0.6× 136 0.8× 111 1.2× 8 0.1× 99 1.4× 19 408

Countries citing papers authored by D. Carvallo

Since Specialization
Citations

This map shows the geographic impact of D. Carvallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Carvallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Carvallo more than expected).

Fields of papers citing papers by D. Carvallo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Carvallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Carvallo. The network helps show where D. Carvallo may publish in the future.

Co-authorship network of co-authors of D. Carvallo

This figure shows the co-authorship network connecting the top 25 collaborators of D. Carvallo. A scholar is included among the top collaborators of D. Carvallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Carvallo. D. Carvallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Niehrs, Christof, Wieland Β. Huttner, D. Carvallo, & Eric Degryse. (1990). Conversion of recombinant hirudin to the natural form by in vitro tyrosine sulfation. Differential substrate specificities of leech and bovine tyrosylprotein sulfotransferases.. Journal of Biological Chemistry. 265(16). 9314–9318. 55 indexed citations
2.
Carvallo, D., Alain Van Dorsselaer, Magda Marquet, et al.. (1989). Purification and biochemical characterization of recombinant hirudin produced by Saccharomyces cerevisiae. Biochemistry. 28(7). 2941–2949. 49 indexed citations
3.
Balland, Alain, T. Faure, D. Carvallo, et al.. (1988). Characterisation of two differently processed forms of human recombinant factor IX synthesised in CHO cells transformed with a polycistronic vector. European Journal of Biochemistry. 172(3). 565–572. 25 indexed citations
4.
Boudier, Christian, D. Carvallo, M Bruch, et al.. (1988). Human Bronchial Proteinase Inhibitor: Rapid Purification Procedure and Inhibition of Luecocyte Elastase in Presence and in Absence of Human Lung Elastin. Advances in experimental medicine and biology. 240. 115–122. 1 indexed citations
5.
Loison, G., Annie Findeli, Magda Marquet, et al.. (1988). Expression and Secretion in S. Cerevisiae of Biologically Active Leech Hirudin. Nature Biotechnology. 6(1). 72–77. 65 indexed citations
6.
Balloul, Jean‐Marc, P. Sondermeyer, Dominique Dreyer, et al.. (1987). Molecular cloning of a protective antigen of schistosomes. Nature. 326(6109). 149–153. 211 indexed citations
7.
Balloul, Jean‐Marc, Denis Boulanger, P. Sondermeyer, et al.. (1987). Vaccination of baboons with a p28 antigen of S. mansoni expressed in E. coli.. 77–84. 4 indexed citations
8.
Schapira, M, Bernard Waeber, Hans R. Brunner, et al.. (1987). Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment.. Journal of Clinical Investigation. 80(2). 582–585. 22 indexed citations
9.
Boudier, Christian, D. Carvallo, Carolyn Roitsch, Joseph G. Bieth, & Michael Courtney. (1987). Purification and characterization of human bronchial proteinase inhibitor. Archives of Biochemistry and Biophysics. 253(2). 439–445. 14 indexed citations
10.
Jallat, Sophie, D. Carvallo, L.H. Tessier, et al.. (1986). Altered specificities of genetically engineered α1 antitrypsin variants. Protein Engineering Design and Selection. 1(1). 29–35. 58 indexed citations
11.
Schapira, M, et al.. (1986). Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.. Journal of Clinical Investigation. 77(2). 635–637. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter W. Bergum Breakdown of academic impact, for papers by Martine Damonneville Breakdown of academic impact, for papers by Gavin Nicoll Breakdown of academic impact, for papers by Carolann McGuire Breakdown of academic impact, for papers by Tamar Grossman Breakdown of academic impact, for papers by Graeme Woodrow Breakdown of academic impact, for papers by Christopher A. Seid Breakdown of academic impact, for papers by John Swindle Breakdown of academic impact, for papers by Jennifer Sexton Breakdown of academic impact, for papers by Verena Karsten
Rankless by CCL
2026